Pilar

The trials here

What the 4 trials at this site are about, from their registry records.

Conditions

• Lung cancer2 trials
• Chronic myeloid leukaemia1 trial
• Myelodysplastic syndromes1 trial
• Rheumatoid arthritis1 trial

Phase

• Phase 32 trials
• Phase 11 trial
• Phase 21 trial

Status

• Active, not recruiting2 trials
• Terminated2 trials

Lead sponsor

• Novartis Pharmaceuticals4 trials

Running trials

• Active, not recruiting

  An Ascending Dose Study of PIT565 in Participants With Rheumatoid Arthritis

  NCT07029555· Phase 1· Novartis Pharmaceuticals· Source

• Active, not recruiting

  Study of Efficacy and Safety of JDQ443 Single-agent as First-line Treatment for Patients With Locally Advanced or Metastatic KRAS G12C- Mutated Non-small Cell Lung Cancer With a PD-L1 Expression < 1% or a PD-L1 Expression ≥ 1% and an STK11 Co-mutation.

  NCT05445843· Phase 2· Novartis Pharmaceuticals· Source

Closed trials

• Terminated

  Study of JDQ443 in Comparison With Docetaxel in Participants With Locally Advanced or Metastatic KRAS G12C Mutant Non-small Cell Lung Cancer

  NCT05132075· Phase 3· Novartis Pharmaceuticals· Source

• Terminated

  Study of Efficacy and Safety of MBG453 in Combination With Azacitidine in Subjects With Intermediate, High or Very High Risk Myelodysplastic Syndrome (MDS) as Per IPSS-R, or Chronic Myelomonocytic Leukemia-2 (CMML-2)

  NCT04266301· Phase 3· Novartis Pharmaceuticals· Source